336 related articles for article (PubMed ID: 23551022)
1. How should we define and classify exacerbations in chronic obstructive pulmonary disease?
Trigueros Carrero JA
Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):33-41. PubMed ID: 23551022
[TBL] [Abstract][Full Text] [Related]
2. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
3. How can we define well-controlled chronic obstructive pulmonary disease?
Molina París J
Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):3-15. PubMed ID: 23551019
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
Antonescu-Turcu AL; Tomic R
Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
[TBL] [Abstract][Full Text] [Related]
5. Chronic obstructive pulmonary disease exacerbations in emergency departments: predictors of outcome.
Roche N; Rabbat A; Zureik M; Huchon G
Curr Opin Pulm Med; 2010 Mar; 16(2):112-7. PubMed ID: 20019614
[TBL] [Abstract][Full Text] [Related]
6. Exacerbations of COPD.
Pavord ID; Jones PW; Burgel PR; Rabe KF
Int J Chron Obstruct Pulmon Dis; 2016; 11 Spec Iss(Spec Iss):21-30. PubMed ID: 26937187
[TBL] [Abstract][Full Text] [Related]
7. Unsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary disease.
Ozyilmaz E; Kokturk N; Teksut G; Tatlicioglu T
Int J Clin Pract; 2013 Jul; 67(7):691-7. PubMed ID: 23758448
[TBL] [Abstract][Full Text] [Related]
8. [Impact of exacerbations on the clinical course of chronic obstructive pulmonary disease].
Soler-Cataluña JJ; Martínez-García MA; Catalán Serra P; Román Sánchez P
Rev Clin Esp; 2011 Mar; 211 Suppl 2():3-12. PubMed ID: 21596168
[TBL] [Abstract][Full Text] [Related]
9. [Multidimensional impact of COPD exacerbations].
Soler-Cataluña JJ; Martínez-García MÁ; Serra PC
Arch Bronconeumol; 2010 Dec; 46 Suppl 11():12-9. PubMed ID: 21316556
[TBL] [Abstract][Full Text] [Related]
10. Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery.
Miravitlles M; Soler-Cataluña JJ; Calle M; Molina J; Almagro P; Quintano JA; Riesco JA; Trigueros JA; Piñera P; Simón A; López-Campos JL; Soriano JB; Ancochea J;
Arch Bronconeumol; 2012 Jul; 48(7):247-57. PubMed ID: 22561012
[TBL] [Abstract][Full Text] [Related]
11. Predicting the risk of exacerbation in patients with chronic obstructive pulmonary disease using home telehealth measurement data.
Mohktar MS; Redmond SJ; Antoniades NC; Rochford PD; Pretto JJ; Basilakis J; Lovell NH; McDonald CF
Artif Intell Med; 2015 Jan; 63(1):51-9. PubMed ID: 25704112
[TBL] [Abstract][Full Text] [Related]
12. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
Fromer L; Barnes T; Garvey C; Ortiz G; Saver DF; Yawn B
Postgrad Med; 2010 Sep; 122(5):150-64. PubMed ID: 20861599
[TBL] [Abstract][Full Text] [Related]
13. [How exactly can we predict the prognosis of COPD].
Atiş S; Kanik A; Ozgür ES; Eker S; Tümkaya M; Ozge C
Tuberk Toraks; 2009; 57(3):289-97. PubMed ID: 19787468
[TBL] [Abstract][Full Text] [Related]
14. "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.
Tomioka R; Kawayama T; Suetomo M; Kinoshita T; Tokunaga Y; Imaoka H; Matsunaga K; Okamoto M; Hoshino T
Int J Chron Obstruct Pulmon Dis; 2016; 11():207-16. PubMed ID: 26893552
[TBL] [Abstract][Full Text] [Related]
15. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations.
Xu W; Collet JP; Shapiro S; Lin Y; Yang T; Platt RW; Wang C; Bourbeau J
Am J Respir Crit Care Med; 2008 Nov; 178(9):913-20. PubMed ID: 18755925
[TBL] [Abstract][Full Text] [Related]
16. The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients.
Lee SD; Huang MS; Kang J; Lin CH; Park MJ; Oh YM; Kwon N; Jones PW; Sajkov D;
Respir Med; 2014 Apr; 108(4):600-8. PubMed ID: 24456695
[TBL] [Abstract][Full Text] [Related]
17. [Chronic obstructive pulmonary disease--acute bacterial exacerbations].
Kasák V
Klin Mikrobiol Infekc Lek; 2004 Apr; 10(2):68-72. PubMed ID: 15146384
[TBL] [Abstract][Full Text] [Related]
18. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
19. The impact of using different symptom-based exacerbation algorithms in patients with COPD.
Trappenburg JC; van Deventer AC; Troosters T; Verheij TJ; Schrijvers AJ; Lammers JW; Monninkhof EM
Eur Respir J; 2011 May; 37(5):1260-8. PubMed ID: 21177839
[TBL] [Abstract][Full Text] [Related]
20. Global assessment of the COPD patient: time to look beyond FEV1?
Papaioannou AI; Loukides S; Gourgoulianis KI; Kostikas K
Respir Med; 2009 May; 103(5):650-60. PubMed ID: 19167871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
